Press release
Revolutionary Breakthrough for Schizophrenia; Bleuler by 52Platform Receives Funding
Bleuler seeks to redefine clinical management with advanced artificial intelligence and personalized solutions.
The project aims to improve patients' quality of life and optimize healthcare system costs.
52Platform [https://www.52platform.com/], a leader in neuroscientific innovation, has announced Bleuler, a revolutionary project aimed at developing a platform to transform the treatment of schizophrenia. Designed with the most advanced capabilities of artificial intelligence, Bleuler aspires to provide personalized solutions based on accurate data. This international project collaborates with Synaptia Health Group in Spain, MJN Neuro, the National Institute of Neurology and Neurosurgery "Manuel Velasco Suarez" in Mexico, Rey Juan Carlos University, and the investment fund Robby & Co. [https://www.robbyandco.com/]
Schizophrenia affects more than 25 million people worldwide. This disorder poses significant challenges due to variability in patient responses to current treatments. Bleuler, still in the study phase, focuses on developing an innovative clinical approach that combines electroencephalographic biomarkers and advanced cognitive assessments through artificial intelligence.
"Bleuler has the potential to revolutionize schizophrenia healthcare," said Adrian Trejo de la Rosa, CEO and co-founder of 52Platform. "This project is a step toward more precise treatment, which will improve patients' quality of life and give physicians reliable technological tools for making critical decisions. Our vision does not stop here; we want to expand this model to other neurological disorders and continue leading the future of personalized medicine."
The development of Bleuler will be possible thanks to a grant of 973,811.33 from a total budget of 1,604,067, awarded by the Centre for Technological Development and Innovation (CDTI, E.P.E.), a Public Business Entity under the Ministry of Science, Innovation and Universities. This funding, under its program supporting high-impact R&D projects, will allow for advancements in research, validation of the technology, and refinement of the platform design.
Technological innovation at the service of patients
Bleuler aims to detect clinical changes in patients early and adjust treatments according to their individual needs. Current studies include the development of wearable devices capable of monitoring brain activity from home, combined with automated cognitive analysis systems. These tools are designed to improve the quality of care and reduce unnecessary hospitalizations.
The project is expected to be ready for implementation by November 2026. This goal reinforces the commitment of collaborators to provide a solution that optimizes schizophrenia treatment in both public and private institutions. In addition to the clinical impact, Bleuler aims to improve the sustainability of the healthcare system in the long term by reducing costs associated with prolonged treatments. Although the platform is still under development, the projected advancements promise to significantly benefit patients and healthcare systems.
"Bleuler marks the beginning of a new era in personalized medicine," concluded Trejo de la Rosa. "We are committed to developing innovative solutions that not only transform the treatment of schizophrenia but also set new standards for other complex disorders."
About Robby & Co
Based in Palo Alto, California, Robby & Co is an innovative Venture Capital firm focused on supporting and empowering neurodivergent talent, with the team's own experiences serving as the starting point, as the majority of its members are neurodivergent.
Media Contact
Company Name: Robby & Co LLC
Contact Person: Press Office
Email: Send Email [http://www.universalpressrelease.com/?pr=revolutionary-breakthrough-for-schizophrenia-bleuler-by-52platform-receives-funding]
Country: United States
Website: https://www.52platform.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Revolutionary Breakthrough for Schizophrenia; Bleuler by 52Platform Receives Funding here
News-ID: 3828351 • Views: …
More Releases from Getnews
Friendly Recovery Center Releases New Educational Resource on Anxiety, Dizziness …
New blog explores how anxiety can trigger physical symptoms and explains the nervous system connection
Friendly Recovery Center has announced the release of a new educational blog resource titled "Can Anxiety Cause Dizziness and Blurred Vision? Understanding the Connection". The article is intended to help individuals better understand how anxiety can produce physical symptoms that may feel sudden, intense, and alarming.
Image: https://www.globalnewslines.com/uploads/2025/12/2e11a0964f56d7aab75a478402781b5f.jpg
The newly published resource explains that anxiety is not limited…
Author Eddie Ruzzi Releases Two Science Fiction Novels Amid Rising Interest in P …
Image: https://www.globalnewslines.com/uploads/2025/12/1766537389.jpg
Eddie Ruzzi
Ruzzi's Novels Tackle Institutional Ethics and Technological Extremism in Speculative Settings.
Los Angeles, CA - Author, Musician, and Sound Editor Eddie Ruzzi [https://eddieruzzi.com/]has released two new science fiction novels, Death Ball and Science Pulp Fiction, at a time when political, military, and pulp-format speculative fiction is attracting renewed attention across publishing, streaming, and print platforms. Analysts note a growing audience for works that integrate structured procedural formats with speculative…
Apple Roofing Completes Full Integration of NMC Exteriors, Expanding Minnesota P …
Image: https://www.globalnewslines.com/uploads/2025/12/1767118605.jpg
Plymouth, MN - December 30, 2025 - Apple Roofing, a top-tier national roofing company known for delivering excellence across residential and commercial roofing services, has officially completed the full integration of NMC Exteriors, one of Minnesota's most trusted roofing brands. Effective January 1, 2026, the NMC Exteriors locations in Plymouth and Rochester will begin operating under the Apple Roofing name, ushering in a new era of service, resources, and…
Leonard Cagno Announces Adoption of a New Internal Privacy and Data Handling Sta …
New policy formalizes how client data is collected, used, stored, and reviewed across operations
Leonard Cagno has announced the adoption of a new internal privacy and data handling standard across his business operations, including work connected to wellness and related service areas. The policy formalizes how sensitive information is managed across health insurance, wellness benefits, payroll, and technology integrations.
The updated standard introduces clearer rules around data access, storage, and review. It…
More Releases for Bleuler
52Platform Introduces Bleuler: A Revolutionary Advance in Schizophrenia Treatmen …
Image: https://www.globalnewslines.com/uploads/2025/01/1737641669.jpg
Barcelona - January 24, 2025 - 52Platform [https://www.52platform.com/], a leader in neuroscientific innovation, has announced Bleuler, a groundbreaking project to develop a platform designed to transform the treatment of schizophrenia. Engineered with the most advanced capabilities of artificial intelligence, Bleuler aims to provide personalized solutions based on precise data. This international project involves collaboration with Synaptia Health Group [https://synaptia.es/] in Spain, MJN Neuro, the National Institute of Neurology and…
